Man

Javier Ignacio Campos Acuña

Gestor de Propiedad Intelectual

Universidad Tecnológica Metropolitana

Santiago, Chile

Líneas de Investigación


Educación

  •  Biotecnología, UNIVERSIDAD ANDRES BELLO. Chile, 2021
  •  Ingeniero en Biotecnología Molecular, UNIVERSIDAD DE CHILE. Chile, 2015

Experiencia Académica

  •   Profesor de Laboratorio de Bioquímica Other

    UNIVERSIDAD ANDRES BELLO

    Facultad de ciencias de la vida

    Santiago, Chile

    2018 - 2019

Experiencia Profesional

  •   Gestor de Propiedad Intelectual Full Time

    Universidad Tecnológica Metropolitana

    Santiago, Chile

    2022 - A la fecha

  •   Asistente de Investigación Full Time

    Universidad de los Andes

    Santiago, Chile

    2015 - 2016

  •   Asistente de Investigación Part Time

    Universidad de Chile

    Santiago, Chile

    2014 - 2015


 

Article (12)

The Heteromeric Complex Formed by Dopamine Receptor D-5 and CCR9 Leads the Gut Homing of CD4(+) T Cells Upon Inflammation
Involvement of dopaminergic signaling in the cross talk between the renin-angiotensin system and inflammation
Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation
Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells
Dysregulation and detection of EGFR in oral cancer. A narrative review
Surface Functionalization of Nanobiomaterials for Application in Stem Cell Culture, Tissue Engineering, and Regenerative Medicine
Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3(+) regulatory T cells in skin-transplanted mice
Neuropilin-1(+) regulatory T cells promote skin allograft survival and modulate effector CD4(+) T cells phenotypic signature
Novel core-shell nanocapsules for the tunable delivery of bioactive rhEGF=> formulation, characterization and cytocompatibility studies
Rapamycin-conditioned dendritic cells activated with monophosphoryl lipid A promote allograft acceptance in vivo
Retinaldehyde dehydrogenase activity is triggered during allograft rejection and it drives Th1/Th17 cytokine production
A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines

Patent (1)

Inflammatory Bowel Diseases Therapy Involving Disrupting ccr9:Drdr5 Heteromer Assembly

Proyecto (6)

Heteromers formed by the CCR9 and D5R drive the migration of effector CD4+ T-cells into the colonic lamina propria promoting chronic gut inflammation
Producto Tópico Dental en Base a Nanopartículas y Estatinas para Tratamiento de Enfermedades Periodontales
The development and validation of an antibody-tagged nanoparticle for detection and prevention of transplant rejection
FONDECYT de Iniciación de la investigación "Retinoic acid and IL-33=> the dynamic duo controlling the polarization of T cell-mediated immunity"
Fortalecimiento de líneas de investigación en terapia celular para autoinmunidad y trasplante
Applying the knowledge of murine tolerogenic dendritic cells to the development of tolerogenic monocyte-derived dendritic cells from rheumatoid arthritis (RA) patients aimed at providing a therapeutic strategy for RA treatment.

Review (1)

T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease
1
MARIA MOLINA

Director

Instituto de Ciencias Biomédicas

Universidad de Chile

INDEPENDENCIA, Chile

1
Maria Bono

Profesor titular

Biologia

UNIVERSIDAD DE CHILE

Santiago, Chile

1
Lilian Soto

Rheumatologist

Medicine

CLINICAL HOSPITAL OF UNIVERSIDAD DE CHILE

Santiago, Chile

2
JUAN AGUILLON

PROFESSOR

IMMUNOLOGY PROGRAM

UNIVERSIDAD DE CHILE

SANTIAGO, Chile

3
Rodrigo Pacheco

Associate Investigator; Head of the Laboratory of Neuroimmunology

Fundación Ciencia para la Vida

Santiago, Chile

4
Karina Pino

Group Leader/Associate Professor

Centro de Investigación Biomédica

Universidad de los Andes

Santiago, Chile

1
Ivan Alfaro

Associate Professor, Director of Innovation and Technology Development

Faculty of Medicine

Universidad del Desarrollo

Santiago, Chile

1
Ziyad Haidar

Professor and Scientific Director (Faculty of Dentistry), Founder and Director (BioMAT'X R&D&I - HAiDAR I+D+i LAB), Claustro of Professors (PhD Program in BioMedicine, CiiB, Faculty of Medicine)

BioMAT'X

UNIVERSIDAD DE LOS ANDES

Las Condes, Chile

1
Maria Matus

Principal Investigator

Fundacion Ciencia & Vida

Santiago, Chile

3
Mauricio Campos Mora

Ph.D student

Universidad de Chile

Santiago, Chile

3
Diego Catalán

Associate Professor

Programa Disciplinario de Inmunología

Universidad de Chile

Santiago, Chile

1
Valentina Ugalde

Lab Manager

Laboratorio de Neuroinmunología

Fundación Ciencia & Vida

Santiago, Chile

1
Veronica Ramos

Bioquímico

Inmunologia, VIH y Alergias

Hospital Clínico Universidad de Chile

Santiago, Chile

1
Bárbara Pesce

Profesora Asistente

ICBM

Universidad de Chile

Santiago, Chile

2
Rodrigo Morales

Postdoctoral researcher

Dept. of Medicine Solna (MedS)

Karolinska Institutet

Stockholm, Suecia

1
Constanza Jiménez

Periodoncista

Odontologia

Red de Salud UC Christus

Santiago, Chile

11
Javier Campos

Gestor de Propiedad Intelectual

Universidad Tecnológica Metropolitana

Santiago, Chile